A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis

Overview of attention for article published in New England Journal of Medicine, March 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

news: 12 news outlets
blogs: 5 blogs
twitter: 560 X users
facebook: 5 Facebook pages
reddit: 5 Redditors

f1000: 1 research highlight platform
guideline: 4 clinical guideline sources
bluesky: 3 Bluesky users
podcasts: 4 podcasts

Readers on

mendeley: 367 Mendeley

So far, Altmetric has seen 647 X posts from 560 X users, with an upper bound of 1,897,799 followers.

RT @jaumebosch9: ✅ Congratulations to L China et al for publishing their albumin trial in the NEJM 👏 ✅ The trial did not demonstrate any b…

RT @AmirKazory: Targeted albumin infusion in decompensated cirrhosis does not prevent renal dysfunction but increases adverse events. @ufne…

A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis | New England Journal of Medicine https://t.co/cYSicqJ3Tv

RT @ArgaizR: What happens when you give 10 times the amount of albumin to patients with Cirrhosis just to achieve an arbitrary level of > 3…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 643 additional X posts.